Regulus Therapeutics
RGLS
#8843
Rank
A$0.14 B
Marketcap
$2.16
Share price
0.00%
Change (1 day)
3.22%
Change (1 year)

Regulus Therapeutics (RGLS) - Total debt

Total debt on the balance sheet as of June 2024 : A$1.03 Million

According to Regulus Therapeutics's latest financial reports the company's total debt is A$1.03 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Regulus Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2022-12-31A$9.22 M-5.65%
2021-12-31A$9.77 M61.65%
2020-12-31A$6.04 M-71.05%
2019-12-31A$20.89 M-11.18%
2018-12-31A$23.52 M-7.51%
2017-12-31A$25.43 M-7.4%
2016-12-31A$27.47 M
2014-12-31A$28.58 M126.09%
2013-12-31A$12.64 M29.67%
2012-12-31A$9.75 M-0.01%
2011-12-31A$9.75 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$33.09 B 3,183,929.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$39.20 B 3,771,855.56%๐Ÿ‡ซ๐Ÿ‡ท France
A$10.24 B 985,218.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$51.63 B 4,967,751.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$2.00 B 192,763.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.8 M 4,210.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$79.15 B 7,614,714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA